Instil Bio (TIL) Non-Current Debt (2022 - 2026)

Instil Bio has reported Non-Current Debt for 5 years, with the latest figure at $85.2 million in Q2 2026.

• On a quarterly basis, Non-Current Debt rose 0.91% year-over-year to $85.2 million in Q2 2026; TTM through Jun 2026 was $85.2 million, a 0.91% increase from a year earlier, with the FY2025 full-year figure at $84.8 million, up 0.74% from the prior year.
• Non-Current Debt was $85.2 million for Q2 2026 at Instil Bio, roughly flat from $85.0 million in the prior quarter.
• The five-year high for Non-Current Debt was $85.2 million in Q2 2026, with the low at $49.1 million in Q2 2022.
• Average Non-Current Debt over 5 years is $79.1 million, with a median of $81.9 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Non-Current Debt jumped 65.91% in 2023, then gained 0.5% in 2024.
• Over 5 years, Non-Current Debt stood at $72.4 million in 2022, then gained by 12.55% to $81.4 million in 2023, then advanced by 3.39% to $84.2 million in 2024, then increased by 0.74% to $84.8 million in 2025, then advanced by 0.46% to $85.2 million in 2026.
• The last three Non-Current Debt figures came in at $85.2 million (Q2 2026), $85.0 million (Q1 2026), and $84.8 million (Q4 2025), per Business Quant data.